Integrated Syringe Labels®
  • integrated syringe labels

Integrated Syringe Labels

Research evidence indicates the incidence of errors in prescribing, preparing and administering injectable medicines is higher than for other forms of medicine. Unlabelled syringes pose a significant risk when products are prepared in clinical areas therefore appropriate labelling of syringes is an important requirement for the safe administration of injectable medicines.

In its “Draft Guidance for Industry on Safety Considerations for Container Labels and Carton Labelling Design to Minimize Medication Errors1 the US FDA recommends the use of a transferable or peel-off label for the commercial container of injectable products. This type of label can help minimize the use of unlabelled syringes because the label would be attached to the commercial container closure, present at the point of product preparation, and not be discarded as in the case with other auxiliary labels often provided with the carton.  This is based upon the observations by the FDA that “once an injectable medication is withdrawn from the commercial container closure (e.g. vial or ampoule) into a syringe for administration, the syringe no longer provides information needed by the end user to verify the drug name and strength prior to administration. Such unlabelled medication has led to administration of the wrong drug and wrong strength."

Introducing the new Integrated Syringe Label®

hameln’s range of Ready-to-Use 50 ml vials are now supplied with an Integrated Syringe Labels (ISL®). The ISL® replaces the need for handwritten syringe labels and ensures the contents of prepared syringes will be easier to identify during administration as well as during dose preparation. The labels are designed in such a way that the approved information of the upper label will always remain on the vial and only the ISL® can be removed from the vial for attaching to the syringe.

The labels also incorporate design features as recommended by the Intensive Care Society and Association of Anaesthetists Syringe Labelling in Critical Care Areas Review 2014 (updated 2016)2.

The Integrated Syringe Label® can be applied in four simple steps:

Step 1: peel back the upper label and turn it aside. The upper label remains attached to the vial

Step 2: remove the second label (syringe label) from the vial

Step 3: fix the syringe label onto the syringe

Step 4: draw up the solution once the syringe is labelled

In March 2007, the National Patient Safety Agency published a patient safety alert to promote the safe use of injectable medicines. The alert recommended that Ready-to-Administer (RTA) or Ready-to-Use (RtU) products should be used to minimise risks when preparing and administering injectable medicines.